BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 18511888)

  • 1. Apoptotic cell death in TrkA-overexpressing cells: kinetic regulation of ERK phosphorylation and caspase-7 activation.
    Jung EJ; Kim DR
    Mol Cells; 2008 Jul; 26(1):12-7. PubMed ID: 18511888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutively active Src facilitates NGF-induced phosphorylation of TrkA and causes enhancement of the MAPK signaling in SK-N-MC cells.
    Tsuruda A; Suzuki S; Maekawa T; Oka S
    FEBS Lett; 2004 Feb; 560(1-3):215-20. PubMed ID: 14988025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytosolic accumulation of gammaH2AX is associated with tropomyosin-related kinase A-induced cell death in U2OS cells.
    Jung EJ; Kim CW; Kim DR
    Exp Mol Med; 2008 Jun; 40(3):276-85. PubMed ID: 18587265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic analysis of novel targets associated with the enhancement of TrkA-induced SK-N-MC cancer cell death caused by NGF.
    Jung EJ; Chung KH; Bae DW; Kim CW
    Exp Mol Med; 2016 May; 48(5):e235. PubMed ID: 27229480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel functional interactions between Trk kinase and p75 neurotrophin receptor in neuroblastoma cells.
    Lachyankar MB; Condon PJ; Daou MC; De AK; Levine JB; Obermeier A; Ross AH
    J Neurosci Res; 2003 Jan; 71(2):157-72. PubMed ID: 12503079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular dissection of TrkA signal transduction pathways mediating differentiation in human neuroblastoma cells.
    Eggert A; Ikegaki N; Liu X; Chou TT; Lee VM; Trojanowski JQ; Brodeur GM
    Oncogene; 2000 Apr; 19(16):2043-51. PubMed ID: 10803465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic analysis of novel targets associated with TrkA-mediated tyrosine phosphorylation signaling pathways in SK-N-MC neuroblastoma cells.
    Jung EJ; Lee SY; Kim CW
    Proteomics; 2013 Jan; 13(2):355-67. PubMed ID: 23319303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel cyclophane compound, CPPy, facilitates NGF-induced TrkA signal transduction and induces cell differentiation in neuroblastoma.
    Yamaguchi Y; Tabata K; Asami S; Miyake M; Suzuki T
    Biol Pharm Bull; 2007 Apr; 30(4):638-43. PubMed ID: 17409494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Abl tyrosine kinase enhances nerve growth factor-mediated signaling in Bcr-Abl transformed cells via the alteration of signaling complex and the receptor turnover.
    Koch A; Scherr M; Breyer B; Mancini A; Kardinal C; Battmer K; Eder M; Tamura T
    Oncogene; 2008 Aug; 27(34):4678-89. PubMed ID: 18427551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caveolin-1 inhibits TrkA-induced cell death by influencing on TrkA modification associated with tyrosine-490 phosphorylation.
    Jung EJ; Kim CW
    Biochem Biophys Res Commun; 2010 Nov; 402(4):736-41. PubMed ID: 20977883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cotransfection of TrkA and p75(NTR) in neuroblastoma cell line (IMR-32) promotes differentiation and apoptosis of tumor cells.
    Chen J; Zhe X
    Chin Med J (Engl); 2003 Jun; 116(6):906-12. PubMed ID: 12877805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nerve growth factor cooperates with p185(HER2) in activating growth of human breast carcinoma cells.
    Tagliabue E; Castiglioni F; Ghirelli C; Modugno M; Asnaghi L; Somenzi G; Melani C; Ménard S
    J Biol Chem; 2000 Feb; 275(8):5388-94. PubMed ID: 10681513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TrkA as a life and death receptor: receptor dose as a mediator of function.
    Yan C; Liang Y; Nylander KD; Schor NF
    Cancer Res; 2002 Sep; 62(17):4867-75. PubMed ID: 12208732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel apoptotic pathway induced by nerve growth factor-mediated TrkA activation in medulloblastoma.
    Chou TT; Trojanowski JQ; Lee VM
    J Biol Chem; 2000 Jan; 275(1):565-70. PubMed ID: 10617652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells.
    Zhu ZW; Friess H; Wang L; Bogardus T; Korc M; Kleeff J; Büchler MW
    Clin Cancer Res; 2001 Jan; 7(1):105-12. PubMed ID: 11205897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TrkA induces differentiation but not apoptosis in C6-2B glioma cells.
    Pflug BR; Colangelo AM; Tornatore C; Mocchetti I
    J Neurosci Res; 2001 Jun; 64(6):636-45. PubMed ID: 11398188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nerve growth factor induces apoptosis in human medulloblastoma cell lines that express TrkA receptors.
    Muragaki Y; Chou TT; Kaplan DR; Trojanowski JQ; Lee VM
    J Neurosci; 1997 Jan; 17(2):530-42. PubMed ID: 8987776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinction between differentiation, cell cycle, and apoptosis signals in PC12 cells by the nerve growth factor mutant delta9/13, which is selective for the p75 neurotrophin receptor.
    Hughes AL; Messineo-Jones D; Lad SP; Neet KE
    J Neurosci Res; 2001 Jan; 63(1):10-9. PubMed ID: 11169609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acidic substitution of the activation loop tyrosines in TrkA supports nerve growth factor-dependent, but not nerve growth factor-independent, differentiation and cell cycle arrest in the human neuroblastoma cell line, SY5Y.
    Gryz EA; Meakin SO
    Oncogene; 2003 Nov; 22(54):8774-85. PubMed ID: 14647472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double cysteine trkA mutant exhibiting reduced NGF binding and delayed Erk signaling.
    Jiang H; Movsesyan V; Liu XW; Katagiri Y; Monshipoyri M; Lazarovici P
    J Mol Neurosci; 2001 Dec; 17(3):293-302. PubMed ID: 11859925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.